Skip to content

The plan of optimizing Helicobacter pylori eradication

The plan of optimizing Helicobacter pylori eradication

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024274
Enrollment
Unknown
Registered
2019-07-04
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Sponsors

Hubei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) All subjects met the diagnostic criteria for Hp gastritis: 13C or 14C breath test showed that Hp was positive, with symptoms of abdominal distension, noise, belching and burning. Chronic superficial gastritis with or without chronic atrophic gastritis was diagnosed by gastroscopy, regardless of whether Hp had been eradicated in the past or not, and antibiotics, bismuth or antimicrobial Chinese medicine were discontinued at least 4 weeks before consultation. PPI or gastric mucosal protective agents must be discontinued for at least 2 weeks. (2) Only group D conformed to the following syndromes Syndrome of damp-heat in spleen and stomach: Main symptoms: fullness or pain of abdomen; body distress; sticky stool or runny stool; Secondary syndromes: less food, less stupor; bad breath; bitter mouth; mental sleepiness; Tongue vein: red tongue, yellow greasy fur, pulse number or slippery. (3) The age ranges from 18 to 65 years with no gender limitation. (4) Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: One of the following situations can not be included in this study: (1) Subjects diagnosed by examination as peptic ulcer, gastric cancer, reflux esophagitis, irritable bowel syndrome and other diseases affecting symptoms and manifestations. (2) Signs of infection were obvious, with white blood cells > 10.0*10^9. (3) Antibiotics, bismuth or traditional Chinese medicine with antimicrobial activity were used within 4 weeks, PPI or other gastric drugs were used within 2 weeks. (4) Pregnant and lactating women. (5) Severe primary heart, liver, lung, kidney, blood diseases or serious diseases affecting their survival, such as malignant tumors. (6) Those who cannot give full informed consent due to intellectual or behavioral disorders. (7) Suspected or true history of alcohol and drug abuse. (8) Subjects whose work environment has changed greatly or whose compliance is poor have lost their follow-up visits or failed to awaken follow-up as planned. (9) allergic constitution or drug allergy to test group and control group.

Design outcomes

Primary

MeasureTime frame
Eradication rate of Helicobacter pylori;

Countries

China

Contacts

Public ContactYunlian Hu

Hubei Provincial Hospital of Traditional Chinese Medicine

314326734@qq.com+86 13871061639

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026